The association between serum gamma-glutamyltransferase within normal levels and metabolic syndrome in office workers: A 4-year follow-up study

Korean Journal of Family Medicine

Volumn 33, Issue 1, 2012, Pages 51-58

  Suh, Byung Seong ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Gamma glutamyltransferase; Incidence; Metabolic syndrome

Indexed keywords

EID: 84858233516     PISSN: 20056443     EISSN: 20926715     Source Type: Journal    
DOI: 10.4082/kjfm.2012.33.1.51     Document Type: Article

References (21)

1. The Ministry of Health and Welfare. The Third Korea National Health & Nutrition Examination Survey (KNHANES III), 2005. Seoul: Th e Ministry of Health and Welfare; 2006.
2. Jousilahti P, Rastenyte D, Tuomilehto J. Serum gammaglutamyl transferase, self-reported alcohol drinking, and the risk of stroke. Stroke 2000;31:1851-5.
3. Wannamethee G, Ebrahim S, Shaper AG. Gammaglutamyltransferase: determinants and association with mortality from ischemic heart disease and all causes. Am J Epidemiol 1995;142:699-708.
4. Kim DJ, Noh JH, Cho NH, Lee BW, Choi YH, Jung JH, et al. Serum gamma-glutamyltransferase within its normal concentration range is related to the presence of diabetes and cardiovascular risk factors. Diabet Med 2005;22:1134-40.
5. Kang YH, Min HK, Son SM, Kim IJ, Kim YK. Th e association of serum gamma glutamyltransferase with components of the metabolic syndrome in the Korean adults. Diabetes Res Clin Pract 2007;77:306-13.
6. Nakanishi N, Suzuki K, Tatara K. Serum gammaglutamyltransferase and risk of metabolic syndrome and type 2 diabetes in middle-aged Japanese men. Diabetes Care 2004;27:1427-32.
7. Rantala AO, Lilja M, Kauma H, Savolainen MJ, Reunanen A, Kesaniemi YA. Gamma-glutamyl transpeptidase and the metabolic syndrome. J Intern Med 2000;248:230-8.
8. Pintus F, Mascia P. Distribution and population determinants of gamma-glutamyltransferase in a random sample of Sardinian inhabitants. 'ATS-SARDEGNA' Research Group. Eur J Epidemiol 1996;12:71-6.
9. Lee DH, Blomhoff R, Jacobs DR Jr. Is serum gamma glutamyltransferase a marker of oxidative stress? Free Radic Res 2004;38:535-9.
10. Marchesini G, Brizi M, Bianchi G, Tomassett i S, Bugianesi E, Lenzi M, et al. Nonalcoholic fatt y liver disease: a feature of the metabolic syndrome. Diabetes 2001;50:1844-50.
11. Lee DH, Jacobs DR Jr, Gross M, Kiefe CI, Roseman J, Lewis CE, et al. Gamma-glutamyltransferase is a predictor of incident diabetes and hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Clin Chem 2003;49:1358-66.
12. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
13. World Health Organization Western Pacific Region; International Association for the Study of Obesity; International Obesity Task Force. The Asia-Pacific perspective: redefining obesity and its treatment. Sydney: Health Communications Australia Pty Ltd.; 2000.
14. Oh SW, Lee JG, Kim MS, Jung DW, Kim YJ, Lee S, et al. Relations of serum gamma-glutamyltransferase levels to incidence of the metabolic syndrome. J Korean Acad Fam Med 2008;29:838-43.
15. Lee DS, Evans JC, Robins SJ, Wilson PW, Albano I, Fox CS, et al. Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study. Arterioscler Th romb Vasc Biol 2007;27:127-33.
16. Andre P, Balkau B, Vol S, Charles MA, Eschwege E. DESIR Study Group. Gamma-glutamyltransferase activity and development of the metabolic syndrome (International Diabetes Federation Definition) in middle-aged men and women: Data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR) cohort. Diabetes Care 2007;30:2355-61.
17. Ruttmann E, Brant LJ, Concin H, Diem G, Rapp K, Ulmer H, et al. Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults. Circulation 2005;112:2130-7.
18. Kazemi-Shirazi L, Endler G, Winkler S, Schickbauer T, Wagner O, Marsik C. Gamma glutamyltransferase and longterm survival: is it just the liver? Clin Chem 2007;53:940-6.
19. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001;286:327-34.
20. Freeman DJ, Norrie J, Caslake MJ, Gaw A, Ford I, Lowe GD, et al. C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes 2002;51:1596-600.
21. Ceriello A, Motz E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Th romb Vasc Biol 2004;24:816-23.